Partial restoration of CD20 protein expression and rituximab sensitivity after treatment with azacitidine in CD20-negative transformed diffuse large B cell lymphoma after using rituximab

Junji Hiraga, Akihiro Tomita, Naruko Suzuki, Yusuke Takagi, Michihiko Narita, Yoshitoyo Kagami

Research output: Contribution to journal › Letter › peer-review

3 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Partial restoration of CD20 protein expression and rituximab sensitivity after treatment with azacitidine in CD20-negative transformed diffuse large B cell lymphoma after using rituximab'. Together they form a unique fingerprint.